Our company

CTRS, Cell Therapies Research & Services is an independent French pharmaceutical company* with a strong and growing international presence. The company’s head office is located in Boulogne-Billancourt, in the western suburbs of Paris (France).

*with exclusively private capital

Since our creation in 2002, our ambition has been to develop and commercialize treatments for patients with strong therapeutic needs. We are committed to improving the quality of life of patients and are particularly involved in:

  • hereditary metabolic diseases,
  • onco-haematology,
  • gene and cell therapies.

Creation of Laboratoires CTRS

2002

Partnership with AP-HP for the development of cholic acid

2007

European MA for Orphacol®

2013

Galien and Prescrire’s Gold Pill awards for Orphacol®

Firm honored with Prescrire’s information awards

2014

Galien International Award for Orphacol®

MA for Neofordex®

Firm honored with Prescrire’s information awards

2016

DCP in 12 countries for the Dexliq® MA

2018

« Because every patient has the right to expect treatment »

CTRS has always worked together with public bodies. In more than 15 years, our numerous partnerships have made it possible to offer patients the most appropriate diagnostic and therapeutic solutions for their needs. Because we all have the same ambition to progress in the field of health, we are convinced that it is by pooling our skills that we will be able to develop new therapeutic solutions for patients.

Our values

  • Find solutions that will give patients access to treatment
  • Serve health professionals, our partners and especially patients
  • Be responsive and flexible
  • Provide responsible medical information